Literature DB >> 29327256

Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?

Na Li1,2,3,4, Dobromir Dobrev5,6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29327256      PMCID： PMC5812790          DOI： 10.1007/s00210-018-1463-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  17 in total

Review 1.  Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.

Authors:  Jordi Heijman; Niels Voigt; Stanley Nattel; Dobromir Dobrev
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.

Authors:  Jason Andrade; Paul Khairy; Dobromir Dobrev; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

4.  DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.

Authors:  Huiliang Qiu; Huanlin Wu; Jin Ma; Haiming Cao; Lihua Huang; Wencong Qiu; Ying Peng; Chunhua Ding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-30       Impact factor: 3.000

5.  L-3-n-Butylphthalide protects rats' cardiomyocytes from ischaemia/reperfusion-induced apoptosis by affecting the mitochondrial apoptosis pathway.

Authors:  Y-G Wang; Y Li; C-Y Wang; J-W Ai; X-Y Dong; H-Y Huang; Z-Y Feng; Y-M Pan; Y Lin; B-X Wang; L-L Yao
Journal:  Acta Physiol (Oxf)       Date:  2013-11-29       Impact factor: 6.311

6.  3-N-butylphthalide (NBP) attenuates the amyloid-β-induced inflammatory responses in cultured astrocytes via the nuclear factor-κB signaling pathway.

Authors:  Hong-Mei Wang; Ting Zhang; Jian-Kang Huang; Xiao-Jiang Sun
Journal:  Cell Physiol Biochem       Date:  2013-07-26

Review 7.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

8.  DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model.

Authors:  Fuxu Wang; Jia Ma; Fei Han; Xiujin Guo; Li Meng; Yufeng Sun; Cheng Jin; Huijun Duan; Hang Li; Ying Peng
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

Review 9.  Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times.

Authors:  Syeda Atiqa Batul; Rakesh Gopinathannair
Journal:  Korean Circ J       Date:  2017-08-22       Impact factor: 3.243

Review 10.  Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Authors:  Muhammad Shahzeb Khan; Gregg C Fonarow; Hassan Khan; Stephen J Greene; Stefan D Anker; Mihai Gheorghiade; Javed Butler
Journal:  ESC Heart Fail       Date:  2017-09-04
View more
  1 in total

1.  Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?

Authors:  Henry Sutanto; Dobromir Dobrev; Jordi Heijman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.